XML 49 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Collaboration Agreements, License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail)
$ in Thousands
9 Months Ended
Sep. 30, 2025
USD ($)
AstraZeneca Agreements [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2024 $ (132,097)
Additions (82,494)
Recognized as Revenue (Discontinued Operations) 218,575
Currency Translation and Other (3,984)
Balance at September 30, 2025 0
Drug Product Revenue, Net [Member] | Astellas Agreement [Member] | Europe [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2024 (9,901)
Recognized as Revenue 3,321
Reclassified to Accrued Liability / Accounts Payable 903
Balance at September 30, 2025 $ (5,677)